
Aavalium targets niche and/or difficult-to-source/difficult-to-manufacture products for the US market. Our product development pipeline covers nutraceuticals, pharmaceuticals [generic, 505(b)(2) and NME] and IVDs. We aim to out-license our products/candidates to business partners for further development and/or commercialization. We continually look for partnership opportunities to co-develop new products.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.